| OSCIX | OSMCX | OSCIX / OSMCX | |
| Total Expense Ratio | 0.99 | 2.13 | 46% |
| Annual Report Gross Expense Ratio | 0.99 | 2.13 | 46% |
| Fund Existence | 14 years | 28 years | - |
| Gain YTD | 17.181 | 15.981 | 108% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.76B | 2.76B | 100% |
| Annual Yield % from dividends | 1.65 | 0.48 | 347% |
| Returns for 1 year | 3.46 | 0.82 | 420% |
| Returns for 3 years | 7.80 | 2.40 | 325% |
| Returns for 5 years | -19.89 | -27.38 | 73% |
| Returns for 10 years | 26.95 | 7.46 | 361% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVXCX | 68.50 | 0.53 | +0.78% |
| Smead International Value C | |||
| ISTNX | 98.71 | 0.16 | +0.16% |
| Macquarie Science and Technology R6 | |||
| AWSRX | 17.84 | N/A | N/A |
| Invesco Global Core Equity R | |||
| CSVYX | 55.03 | -0.01 | -0.02% |
| Columbia Small Cap Value Discv Inst 3 | |||
| CLTAX | 17.35 | -0.07 | -0.40% |
| Catalyst/Lyons Tactical Allocation A | |||